Correction: Janjetovic et al. Novel Vitamin D3 Hydroxymetabolites Require Involvement of the Vitamin D Receptor or Retinoic Acid-Related Orphan Receptors for Their Antifibrogenic Activities in Human Fibroblasts. Cells 2024, 13, 239 | Synapse
Correction: Janjetovic et al. Novel Vitamin D3 Hydroxymetabolites Require Involvement of the Vitamin D Receptor or Retinoic Acid-Related Orphan Receptors for Their Antifibrogenic Activities in Human Fibroblasts. Cells 2024, 13, 239
To clarify the roles of vitamin D receptor and retinoic acid-related orphan receptors in the antifibrogenic activities of novel vitamin D3 hydroxymetabolites.
Correction to earlier findings regarding vitamin D3 hydroxymetabolites
Focus on human fibroblast responses
Analysis of the involvement of receptors
Confirmed the necessity of vitamin D receptor for antifibrogenic activity.
Highlighted roles of retinoic acid-related orphan receptors.